⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1308353 | 0.82 | — | — | |
| SCHEMBL263484 | 0.79 | ALOX15 (0.40) | — | |
| SCHEMBL301421 | 0.78 | — | — | |
| SCHEMBL9331253 | 0.77 | — | — | |
| SCHEMBL4588023 | 0.77 | — | — | |
| SCHEMBL3073342 | 0.77 | — | — | |
| SCHEMBL2649139 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL28986368 | 0.76 | — | — | |
| Iodide SCHEMBL28874069 | 0.76 | — | — | |
| SCHEMBL28666100 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116322645-A | Liquid formulations of long acting conjugates of GLP-2 | 韩美药品株式会社 | 2023-06-23 | — | — | CN | claimed |
| CN-108026143-B | Method for preparing physiologically active polypeptide conjugate | 韩美药品株式会社 | 2022-05-27 | — | — | CN | claimed |
| CN-110269930-A | The liquid preparation of protamine zine insulin and insulinoptropic peptides | 韩美药品株式会社 | 2019-09-24 | — | — | CN | claimed |
| CN-108026143-A | Process for preparing physiologically active polypeptide conjugate | 韩美药品株式会社 | 2018-05-11 | — | — | CN | claimed |
| CN-102112493-B | A polypeptide complex comprising non-peptidyl polymer having three functional ends | HANMI PHARMACEUTICAL CO LTD | 2015-04-01 | — | — | CN | claimed |
| EP-2643000-A2 | THERAPEUTIC PIPERAZINES | Dart Neuroscience (Cayman) Ltd (KY) | 2013-10-02 | — | — | EP | claimed |
| WO-2012040258-A2 | THERAPEUTIC PIPERAZINES | HELICON THERAPEUTICS, INC. (US) | 2012-03-29 | — | — | WO | claimed |
| US-20110065691-A1 | THERAPEUTIC PIPERAZINES | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2011-03-17 | — | — | US | claimed |
| EP-1246836-A2 | PEPTIDES FOR TREATMENT OF ERECTILE DYSFUNCTION | Ardana Bioscience Limited (GB) | 2002-10-09 | — | — | EP | claimed |
| EP-1142867-A2 | Cell adhesion inhibitors | BIOGEN, INC. (US) | 2001-10-10 | — | — | EP | claimed |
| WO-1998022610-A1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1998-05-28 | — | — | WO | claimed |
| EP-0752860-A4 | ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR | COCENSYS INC (US) | 1998-05-06 | — | — | EP | claimed |
| EP-0752860-A1 | ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR | COCENSYS, INC. (US) | 1997-01-15 | — | — | EP | claimed |
| US-5574016-A | Peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-12 | — | — | US | claimed |
| US-5512588-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-30 | — | — | US | claimed |
| WO-1995021617-A1 | ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR | COCENSYS, INC. (US) | 1995-08-17 | — | — | WO | claimed |
| EP-0315367-B1 | Polypeptides | ICI PLC (GB) | 1994-04-06 | — | — | EP | claimed |
| WO-1993002689-A1 | SYNTHETIC RIBONUCLEASES AND METHODS FOR PREPARING AND USING SAME | UNIVERSITY OF MEDICINE & DENTISTRY (US) | 1993-02-18 | — | — | WO | claimed |
| US-5068222-A | Polypeptides for treatment of cancer | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-11-26 | — | — | US | claimed |
| EP-0315367-A2 | Polypeptides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-10 | — | — | EP | claimed |